Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. RemeGen Co., Ltd.
  6. Revisions
    9995   CNE1000048G6

REMEGEN CO., LTD.

(9995)
  Report
Delayed Hong Kong Stock Exchange  -  10:32 2022-09-26 pm EDT
38.10 HKD   +2.01%
09/20RemeGen Announces Preliminary Results of Phase III Confirmatory Study of Telitacicept for Treatment of Systemic Lupus Erythematosus (SLE) in China
AQ
09/19RemeGen Completes Third Phase of Clinical Study For Lupus Treatment In China
MT
09/19RemeGen Co., Ltd. Announces Preliminary Result of Telitacicept in the Phase III Comfirmatory Study to Treat Systemic Lupus Erythematosus in China
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions